Note 13 (heart and cholesterol)

اینڈروئیڈ ایپ تجزیہ اور جائزہ: Note 13 (heart and cholesterol) ، GeminiSoftware کے ذریعہ تیار کیا گیا۔ طبی زمرہ میں درج ہے۔ موجودہ ورژن 1.0 ہے ، 19/09/2013 کو اپ ڈیٹ ہوا۔ گوگل پلے پر صارفین کے جائزوں کے مطابق: Note 13 (heart and cholesterol). 2 ہزار سے زیادہ انسٹال حاصل کیا۔ Note 13 (heart and cholesterol) کے فی الحال 1 جائزے ، اوسط درجہ بندی 5.0 ستارے ہیں

note 13 aifa (Italian drug agency) is an articulated and complex text, continuously updated and therefore not easy to know and apply.
This application is a relief to the prescriber: in 4 easy data entry step can stratify patient risk and identify the ottimale.step Therapy 1: Data pazientesemplicemente total cholesterol and LDL, sex and habits tabagicastep 2: associatecondizioni conditions
Sunglasses stratify the risk as high or very high (a check-list of 8 elements, grouped into 4 categories) .step 3: dyslipidemias familiaridiagnosticate on the basis of simplified criteria: first biochemical criteria are tested (is required, additionally, only
the triglyceride range) and, if these are compatible, are required as well as some anamnestic-family criteria (a quick check-list of items 2-5) .step 4: rischioin cards case of negativity of all the above steps, the risk
it is stratified on the basis of "risk maps" esc, crossing the total cholesterol, already included with those of the age group and goes
lore of arterial pressure sistolicarisultatoa this point comes the final result: 1.
estimated risk for the patient (very high, high, moderate, medium, mild) and cardiovascular mortality waiting to 10 years; 2.
ldl therapeutic target, ie to achieve optimal value for that patient; 3.
ldl percentage reduction necessary to achieve the target; 4.
indicated therapy, according to the progressive levels, based on the initial response;
They are also shown any "additional therapies" to optimize the lipid profile (HDL, triglycerides), in addition to control of the target ldl; 5.
a "dose" button opens the representative histogram of the power of statins in various dosages, helping in the choice, depending on the percentage of killing ldl necessary calcolata.questa application follows the most 'can faithfully the indications of the note aifa, tend account that,
for the complexity, one can find conditions not clearly coded by the known, often for actual lack of scientific evidence relating to particular issues;
for example, is not a clear indication of the cutt-off of triglyceride values ​​trattare.per issues be directly consult the text of the official gazette.
and 'to point out, moreover, as the risk stratification of the proposal by the ministry be inspired, but not completely tracings as suggested by esc.si guidelines, finally, that the application of the rules of the note 13 is not a mere bureaucratic exercise but an act
doctor aimed at prognostic stratification of the patient and the formulation of the most suitable therapy, with significant implications on the outcome of the patient in the long termine.disclaimer: the author assumes no liability arising from the application.
It invites those who use it to verify the result and apply it correctly to the clinico.key-context words: heart, cardiology, dyslipidemia, triglycerides, cholesterol, LDL, HDL, therapy, cardiovascular drugs, statins, ezetimibe, pufa n3, fibrate,
nota13 the application has been entirely developed (diagnostic-therapeutic algorithm drafting, technical development, graphics solutions) by Dr. francesco gemelli, cardiologist roma.
for any questions, comments or suggestions, I am willingly available and can be contacted at the following address: [email protected]

Read more